Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program
- 3 October 2019
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 68 (12), 2337-2349
- https://doi.org/10.2337/db19-0236
Abstract
Novel biomarkers of type 2 diabetes (T2D) and response to preventative treatment in individuals with similar clinical risk may highlight metabolic pathways that are important in disease development. We profiled 331 metabolites in 2,015 baseline plasma samples from the Diabetes Prevention Program (DPP). Cox models were used to determine associations between metabolites and incident T2D, as well as whether associations differed by treatment group (i.e., lifestyle [ILS], metformin [MET], or placebo [PLA]), over an average of 3.2 years of follow-up. We found 69 metabolites associated with incident T2D regardless of treatment randomization. In particular, cytosine was novel and associated with the lowest risk. In an exploratory analysis, 35 baseline metabolite associations with incident T2D differed across the treatment groups. Stratification by baseline levels of several of these metabolites, including specific phospholipids and AMP, modified the effect that ILS or MET had on diabetes development. Our findings highlight novel markers of diabetes risk and preventative treatment effect in individuals who are clinically at high risk and motivate further studies to validate these interactions.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK048489)
This publication has 39 references indexed in Scilit:
- Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic ApproachDiabetes, 2013
- Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in HumansJournal of the American College of Cardiology, 2012
- Novel biomarkers for pre‐diabetes identified by metabolomicsMolecular Systems Biology, 2012
- Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humansJCI Insight, 2011
- Interactions of plasmalogens and their diacyl analogs with singlet oxygen in selected model systemsFree Radical Biology & Medicine, 2011
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- Exercise-Induced Changes in Metabolic Intermediates, Hormones, and Inflammatory Markers Associated With Improvements in Insulin SensitivityDiabetes Care, 2010
- Lipid-induced insulin resistance: unravelling the mechanismThe Lancet, 2010
- Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetesThe Journal of Experimental Medicine, 2008
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001